ProPhase Labs Inc (PRPH) outlines cost-cutting measures and potential liquidity events amid financial constraints and stock price concerns.

About 100 cells divide every second in our body. A key protein in cell division is a protein kinase termed Plk1, because it activates other proteins involved in this process. Plk1 is also ...

Net revenue for the year ended December 31, 2024, decreased $28.2 million, or 80.6%, to $6.8 million compared to $35.0 million for the year ...

A live webcast of the fireside chat will be available through the investor relations section of the NewAmsterdam Pharma website at ir.newamsterdampharma.com. Following the live webcast, an archived ...

ProPhase Labs (NASDAQ:PRPH) is scheduled to announce FY earnings results on Monday, March 31st, before market open. The consensus EPS Estimate is -$0.24 (+75.5% Y/Y) and the consensus Revenue Estimate ...

Analysts anticipate ProPhase Labs to report an earnings per share (EPS) of $-0.24. The market awaits ProPhase Labs's ...

Reliv International Inc (RELV) is expected to report for 4Q. Rubicon Technology Inc (RBCN) is expected to report for 4Q. Ryvyl Inc (RVYL) is expected to report $-0.33 for 4Q. SouthGobi Resources Ltd ...

Durect (DRRX) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of $0.06. This compares to loss of $0.27 per share a year ago. These figures are adjusted for ...

Cells constantly shift and transform, triggering the complex choreography that shapes living organisms. Whether dividing into new cells or sculpting an embryo, these tiny movements rely on chemical ...

CFO bought 1.5 million worth on March 5th, a Price/Book ratio of 0.43x and a Net Current Assets Value (NCAV) of 0.68x that day. Now it's trading at 0.47x Price/Book Value and 0.72x NCAV, showing a ...

NEW YORK, NY / ACCESS Newswire / March 18, 2025 /The Investor Summit is excited to announce that presentations from Q1 ...